Jinan Hongjitang Pharmaceutical Co., Ltd. was founded in 1907. It has a history of 100 years with Beijing Tongrentang. The company has undergone changes such as Hongjitang, Hongji Pharmaceutical Factory, Jinan People's Pharmaceutical Factory, Shandong Jinan Traditional Chinese Medicine Factory, etc. In 1999, it was restructured into Jinan Hongjitang Pharmaceutical Co., Ltd. In October 2002, it was integrated with Linuo Group and became its core enterprise. In 2006, it was rated as a "Chinese time-honored brand" enterprise by the Ministry of Commerce. In 2003, the company moved to No. 360, Hualong Road, National High-tech Zone, and invested 200 million yuan to build a new plant. 11 dosage forms achieved GMP certification at one time and became a model enterprise in Shandong Province. The company has a research and development center, which has successively developed national first and third category new drugs such as musk ketone, Jinming tablets, children's digestion tablets, Shengxueling granules, and Qianliexin capsules. The leading varieties independently developed account for more than 80% of the company's profits and sales. Four main products, "Qianliexin Capsule, Xiaoer Xiaoshi Tablet, Xiling Jiedu Tablet, Houzheng Pill", were recognized as "Shandong Famous Brand Products". In 2005, the "Hongjitang" trademark was rated as "Shandong Famous Trademark". In 2006, it was recognized as a well-known trademark in China. The company not only strengthened the GMP management of drugs, but also achieved ISO9001, ISO14001, GB/T28001 three international system certifications in 2005, timely connecting with international enterprises. In May 2006, the company was awarded the Shandong Province Traditional Chinese Medicine Modernization Demonstration Enterprise. Since the beginning of the company, especially since the restructuring in 1999, the company has established a focus on traditional Chinese medicine, making traditional Chinese medicine refined, excellent and strong, and incorporating the scientific and technological innovation strategy into the company's overall development strategy. The company timely implemented various scientific and technological reform plans, established and improved the technological innovation system, adjusted the organizational structure of technological innovation, enhanced the ability of technological innovation, and carried out fruitful reforms in the software and hardware of scientific and technological development. Scientific and technological innovation results continue to emerge. Musk ketone, Jinming tablets, Xiaoer Xiaoshi tablets, Shengxueling granules, Qianliexin capsules, Musk Xintongning tablets and other varieties with independent intellectual property rights have been developed, and they have become the source of power for the company's sustainable development. The company's production center is located at No. 360, Hualong Road, covering an area of 68,000 square meters, a construction area of 45,000 square meters, and a total investment of 200 million yuan. It is designed according to the highest level of the domestic pharmaceutical industry, and all dosage forms fully meet GMP requirements. It mainly includes preparation building, extraction building, pretreatment building, fully automatic elevated warehouse, power engineering building, synthetic musk ketone building, restaurant office building, etc. The engineering design fully meets environmental protection requirements, and the greening rate of the factory area will reach more than 50%. The equipment is of the highest domestic level, and some are foreign equipment. The most advanced technology is used. The extraction and powder making, purification air conditioning, and high-bay warehouse will all adopt automatic control systems. The preparation production process adopts a central monitoring system, and all information management is introduced. The company's production capacity can reach 3 billion tablets, 500 million capsules, 100 tons of granules, 20 million large honey pills, 10 million bags of small honey pills, 5 million bags of water pills, 30 million boxes of micro-pills, 50 million oral liquids, 2,000 tons of extraction, 2,000 tons of powder making, and 300 kilograms of synthetic musk ketone. The production area of modern dosage forms such as soft capsules and dripping pills is reserved. The company's R&D center has complete hardware facilities and a superior research environment. The laboratory is equipped with high-precision test and detection equipment such as gas chromatograph, high-performance liquid chromatograph (ultraviolet detector, evaporative light detector), dual-wavelength thin-layer scanner, rotary thin film evaporator, electronic analytical balance, ultraviolet spectrophotometer, infrared chromatograph, etc., which fully meet the needs of product and technology research and development. The company's R&D center has developed more than 50 national new drugs, including artificial musk ketone, a national first-class new drug, eight protected varieties of traditional Chinese medicine, and 15 patents. Every year, many new products are put on the market. The "Fei Tong Oral Liquid" for the treatment of interstitial pneumonia, which is currently under development and can fill the domestic gap, will obtain a new drug approval certificate by the end of 2008. The artificial musk ketone, a national first-class new drug developed by the R&D center, has completed national confidentiality protection. In terms of scale and efficiency, it has become the largest and most technologically advanced production base in Asia, and has become a demonstration enterprise and leader in technological innovation in this field among the same industry in the country. Hongjitang's sales network covers the whole country, and the international market covers Southeast Asia, Japan and South Korea, the United States, Russia, the European Community, the Middle East, Africa and other countries and regions. It has established a marketing mechanism that organically combines brands, market networks, and marketing teams, and adheres to the marketing strategy of "specialization, clustering, and differentiation"; it has formed a marketing team composed of various teams such as brand planning, professional marketing, and terminal promotion, which has super group coordination and overall combat capabilities; it has established a complete international and domestic market sales network; and it has realized the integrated operation of R&D, marketing, and production. The company insists on carrying forward the corporate culture of "spreading great virtue and benefiting the world", upholding the modern business philosophy of "integrity, innovation, win-win, dedication" and "innovation and change, pursuit of excellence", and fully implementing the development strategy of "brand, scale, and efficiency". The century-old Hongjitang is making every effort to move towards the goal of specialization, modernization, and internationalization of traditional Chinese medicine.